News
Biochemist Svetlana Mojsov, honored for GLP-1 research that has transformed metabolic disease care, says she’s grateful to ...
An important point about the updated guidelines is the emphasis on individualized treatment of complicated UTIs, recognizing ...
Key Points President Trump has threatened to levy tariffs of up to 200% on pharmaceutical imports.Lilly's margins could be negatively affected if the company absorbs the higher costs.However, any ...
An investigation by Democratic senators has raised concerns about conflicts of interest in telehealth companies' ties to ...
The Food and Drug Administration has authorized Juul's original vaporizer and flavored cartridges to remain on the U.S.
The sale represents Clever Culture’s fifth engagement with a leading pharma manufacturer, including AstraZeneca, Bristol Myers Squibb and Thermo Fisher. The company is due to report its Q4 FY25 ...
Explore more
After a nine-month investigation into direct-to-consumer telehealth platforms launched by Eli Lilly and Pfizer, a group of ...
Taking a page from Eli Lilly and Novo Nordisk, who have launched online programs to sell their diabetes and obesity drugs ...
Report found business relationships between telehealth and pharma companies may indirectly lead patients toward certain ...
Fort Wayne was No. 24 on LinkedIn’s list. LinkedIn called Fort Wayne a “city on the rise” because “a wave of new investments in data centers and tech infrastructure, coupled with affordable housing ...
An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki’s ...
Shares of Johnson & Johnson climbed 6.8% in morning trading, enough to pace the S&P 500 index's SPX gainers. They were also headed for their biggest one-day gain and best postearnings reaction since ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results